Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Epilepsy Behav. 2021 Jan 23;116:107732. doi: 10.1016/j.yebeh.2020.107732

Table 1.

Summary of patient dose, duration, and side effects to memantine

Patient Final Dose Duration Side Effects
1 10 mg/day 3.10 years (began at age 11.7 years) Ceased temporarily due to nausea and vomiting; restarted with no additional side effects
2 20 mg/day 2.3 years (began at age 8.5 years) None reported
3 20 mg/day 11 months (began at age 4.5 years) None reported
4 5 mg/day 1.4 years (began at age 16.11 years) None reported
5 40 mg/day 4.8 years (began at age 5.3 years) None reported